Shareholders approve 2025 Equity Incentive Plan authorizing 3.47M new shares

COLLEGIUM PHARMACEUTICAL, INC

Shareholders voted 20.3M for, 7.1M against to approve the 2025 Equity Incentive Plan.
Plan authorizes 3,474,404 shares for issuance to employees, directors, and consultants.
All eight director nominees elected; say-on-pay and auditor ratification also approved.
Director compensation capped at $750k annually ($1M first year).
Vesting minimum of one year for awards, except up to 5% of shares can have shorter vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.